Synthes reported consolidated sales of $992 million during the second quarter of 2011, an 11.2 percent increase over the same period last year, according to a company news release.
The company's comprehensive pedicle screw system, which was launched during the fourth quarter of 2010, has continued to expand and exceed expectations in the United States market. Despite the weak economy, the company experienced growth in the North American and European trauma markets.
The sales growth rate declined in the rest of the world, due to a one time effect of the Middle Eastern tender order delivery, according to the report.
Read the financial report for Synthes.
Related Articles on Device Companies:
InVivo Therapeutics Reports Increased Net Loss During Q2
Knee Business Big for Smith & Nephew's 9% Revenue Increase in 2Q
TranS1 Revenues Continue to Slide in 2Q With 26% Decrease
The sales growth rate declined in the rest of the world, due to a one time effect of the Middle Eastern tender order delivery, according to the report.
Read the financial report for Synthes.
Related Articles on Device Companies:
InVivo Therapeutics Reports Increased Net Loss During Q2
Knee Business Big for Smith & Nephew's 9% Revenue Increase in 2Q
TranS1 Revenues Continue to Slide in 2Q With 26% Decrease